Living Donor Liver Transplant in a Patient with Decompensated Chronic Liver Disease and Associated Complications

PACE Hospitals

A 41-year-old female presented to PACE Hospitals, Hyderabad, with complaints of abdominal distension, jaundice for 20 days, and significant weight loss with loss of appetite for three months. She was diagnosed with decompensated chronic liver disease (DCLD). A living donor liver transplant (LDLT) was performed successfully.

Chief complaints

A 41-year-old female patient presented to PACE Hospitals, Hitech City, Hyderabad, with chief complaints of progressive abdominal distension and yellowish discoloration of the eyes for 20 days. She also reported loss of appetite and significant weight loss over the past three months.

Medical history

The patient had a history of Type II Diabetes Mellitus diagnosed eight years ago, managed with insulin therapy. Additionally, she was diagnosed with triple vessel-coronary artery disease via coronary angiography and was on medical management with clopidogrel and atorvastatin therapy.

She was a known case of decompensated chronic liver disease, complicated by portal hypertension, jaundice, ascites, and hepatorenal syndrome.

No prior history of gastrointestinal bleeding, shortness of breath, altered behavior, reversed sleep cycle, pedal edema, large-volume paracentesis, or decreased urine output was reported.

Diagnosis

The patient was diagnosed with decompensated chronic liver disease (DCLD) with complications including hepatorenal syndrome, portal hypertension, jaundice, and ascites. The MELD-Na score was 26, and the CTP classification was Class C, indicating advanced liver failure.

Treatment

Following a detailed transplant workup, pre-anesthetic clearance, and evaluation by Dr. Suresh Kumar S, a living donor liver transplant (LDLT) was planned. The patient’s brother was deemed a suitable donor.

Surgical findings

Intraoperative findings revealed a macronodular, cirrhotic liver with significant ascites. The portal vein was patent, and no space-occupying lesions or peritoneal or pelvic deposits were identified. A modified right lobe graft was harvested from the donor, and a neo-middle hepatic vein was constructed using segments 5 and 8 veins with a polytetrafluoroethylene (PTFE) graft.

Postoperative care

The postoperative period was uneventful. Daily Doppler ultrasounds confirmed normal graft perfusion, and immunosuppressive therapy was initiated promptly. The patient was started on an oral liquid diet by postoperative day 3. She received comprehensive supportive care, including intravenous fluids, antibiotics, antifungals, proton pump inhibitors (PPIs), multivitamins, antiemetics, analgesics, and antipyretics.

During the hospital stay, the patient developed right-sided pleural effusion, leading to shortness of breath. An intercostal chest drain (PCD) was inserted and placed under water seal. Serial monitoring showed a gradual decrease in drain output, improved lung expansion, and eventual removal of the PCD. The right abdominal drain was removed, while the left drain remained in situ at the time of discharge.

Discharge notes

The patient was discharged in hemodynamically stable condition. Discharge medications included antibiotics, immunosuppressants, corticosteroids, diuretics, PPIs, hepatoprotective agents, beta blockers, calcium supplements, antiplatelets, and opioids. Detailed instructions were given regarding fasting blood sugar monitoring two hours after breakfast or at bedtime on alternate days.

She was advised to avoid crowded places, wear a mask, follow a high-protein diet, and maintain proper drain and wound care.

She was also instructed to report immediately to the emergency ward of PACE Hospitals, Hyderabad, in case of any adverse symptoms, such as vomiting, fever, or abdominal pain.

Follow-up plan

The first review was scheduled four days after discharge in the Surgical Gastroenterology Outpatient Department (SGE OPD), where blood counts (CBP), renal function tests (RFT), liver function tests (LFT), and tacrolimus levels were to be checked.

Another review with an endocrinologist was planned after seven days post discharge, along with a glucose chart review for diabetes management.

Role of living donor liver transplantation in decompensated chronic liver disease

Living Donor Liver Transplantation (LDLT) is a critical treatment option for patients with chronic liver disease, offering a lifesaving solution when the liver fails to function adequately. In LDLT, a portion of a healthy liver from a living donor is transplanted into the patient, leveraging the liver's regenerative capability. This procedure is particularly beneficial in regions with limited access to deceased donor organs. It provides excellent survival rates, reduced waiting times, and faster recovery. LDLT is performed under stringent donor-recipient matching and requires multidisciplinary care for successful outcomes.